Newvale Capital LLC

About

NewVale Capital Go to Main Content About Approach Team Companies News Contact Investor Login Investing in the Services Architecture Behind Life Sciences Built for the Gap Between Proof and Scale NewVale Capital is a sector-specialist pharma services growth equity firm investing in proven, revenue-generating services and enabling technology businesses serving the life sciences ecosystem. We partner with management teams to provide right-sized capital and focused support to enhance commercial execution, strengthen core infrastructure, and build durable, scalable platforms. Learn More About Us A Defined Strategy for Life Sciences We invest exclusively in the services architecture that underpins the life sciences ecosystem – leveraging deep customer knowledge and connectivity to drive operational improvement and sustainable commercial growth. What we invest in Drug Discovery Lab and research services and enabling technologies that support early stage drug discovery. Clinical Research Services and enabling technologies that support clinical research and clinical trial execution. Manufacturing & Supply Chain Services and enabling technologies that support pharmaceutical manufacturing, quality, and supply chain operations. Commercialization Services and enabling technologies that support launch execution, adoption, and ongoing performance of commercial therapeutics. Our Partner Companies Aizon is a GxP-compliant, AI-enabled, software platform purpose-built for pharmaceutical manufac

Key Contact